← Stock Trading Canary · All insider profiles
INSIDER PROFILE · FR
BPIFRANCE INVESTISSEMENT SAS
ADMINISTRATEUR | Administrateur
Profile key: fr|bpifrance investissement sas
Purchase history
- Companies traded
- 6
- Purchases · 12M
- 6
- Purchases · 24M
- 9
- Average purchase
- €2,508,145
- Gross purchase value
- €22,573,304
- Last purchase
- 2026-07-23
- Completed 20D events
- 9.0
- Outcome status
- PASS
Latest company: DIAGNOSTIC MEDICAL SYSTEMS
Companies: ADVICENNE | AFYREN | DIAGNOSTIC MEDICAL SYSTEMS | FORSEE POWER | IEVA GROUP | MAAT PHARMA
Post-purchase outcomes
Benchmark-relative outcomes are available against CAC 40.
- Excess return = stock return − CAC 40 return over the same period.
- Hit rate = positive excess-return events ÷ completed events.
- Price coverage = valid point-in-time prices ÷ events mature enough for that period.
- Returns start on the first shared trading session on or after publication.
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 9Developing | 100.0% (9/9) | 77.8% (7/9) | +3.9% | +2.8% | -4.0% |
| 20D | 9Developing | 100.0% (9/9) | 44.4% (4/9) | -0.0% | -0.5% | -11.9% |
| 60D | 9Developing | 100.0% (9/9) | 33.3% (3/9) | -1.8% | +9.1% | -16.0% |
| 120D | 5Developing | 100.0% (5/5) | 40.0% (2/5) | -7.8% | +9.8% | -30.3% |
Research patterns
- First purchase in 12M
- 4/6
- Large purchase ≥ €100k
- 6/9
- Cluster buying · 15D
- 0/9
- Buying the dip · ≥20% below prior 52W high
- 6/6
- Routine / opportunistic
- Not classifiable
Counts are profile-wide, point-in-time research labels. They never affect the insider score or ranking.
Every completed outcome is shown; n<5 is descriptive small-sample evidence and is not scored. Disclosure-level observations published on the same date may share a return path and may not be statistically independent. These results never affect the insider score or ranking.